News|Articles|May 15, 2020
- Pharmaceutical Technology-05-15-2020
- Volume 2020 eBook
- Issue 2
Minimizing Contamination During Biopharma R&D
Author(s)David Phillips
The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.
Advertisement
The right approach to biological safety cabinets (BSC), and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination. This article summarizes the key criteria for assessing BSC performance so that it prevents contamination.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 34–37
Citation
When referring to this article, please cite it as D. Phillips, "Minimizing Contamination During Biopharma R&D," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).
Articles in this issue
over 6 years ago
On Point: Biologics Drive Growth in Pre-Filled Syringesover 6 years ago
Instrumenting Single-Use Processesover 6 years ago
Considerations in Contamination Controlover 6 years ago
Best systems and equipment for contamination controlover 6 years ago
Building Data Quality In Generates Quality Data Outover 6 years ago
Detecting Contamination in Cell Therapiesover 6 years ago
Optimizing Viral Vector Manufacturing for Gene Therapyover 6 years ago
Complications in Process Simulation ExecutionAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
3
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
4
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
5